These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 9833081)

  • 1. [Heart and brain: are the risk factors the same? Are the results of primary and secondary trials comparable?].
    Castaigne A; Haziza F; Lopes-Darmon ME
    Arch Mal Coeur Vaiss; 1998 Oct; 91 Spec No 5():59-63. PubMed ID: 9833081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials.
    Yusuf S; Lessem J; Jha P; Lonn E
    J Hypertens Suppl; 1993 Jun; 11(4):S61-73. PubMed ID: 8104243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk factors and age].
    Steinmann B
    Schweiz Med Wochenschr; 1975 Mar; 105(12):373-8. PubMed ID: 1138358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of risk factors of coronary atherosclerosis].
    Guize L; Iliou MC
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11 Suppl):1687-93. PubMed ID: 1304142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of myocardial infarct?].
    Turini GA; Brunner HR
    Schweiz Med Wochenschr; 1978 Apr; 108(15):545-50. PubMed ID: 644271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heparin in the treatment and secondary prevention of myocardial infarction. A critical review of the main trials].
    Kher A; Samama M; Haïat R
    Arch Mal Coeur Vaiss; 1991 Nov; 84(11):1581-6. PubMed ID: 1662479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of cerebral infarct caused by atherosclerosis].
    Mas JL
    Arch Mal Coeur Vaiss; 1998 Oct; 91 Spec No 5():65-73. PubMed ID: 9833082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Siblings of myocardial infarction patients are overlooked in primary prevention of cardiovascular disease.
    Hengstenberg C; Holmer SR; Mayer B; Engel S; Schneider A; Löwel H; Riegger GA; Schunkert H
    Eur Heart J; 2001 Jun; 22(11):926-33. PubMed ID: 11428816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary prevention of coronary thrombosis by antithrombotic agents].
    Milon H; Lantelme P; Khettab F; Mestre-Fernandes C; Lasserre-Remy S
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1243-50. PubMed ID: 11794965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Life style and prevention of cerebrovascular accidents].
    Labauge R; Aboobaker-Labauge F
    World Health Stat Q; 1991; 44(2):74-9. PubMed ID: 1926896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol-lowering drugs. Some drugs with demonstrated efficacy but different benefits in primary and secondary prevention.
    Prescrire Int; 1999 Aug; 8(42):116-20. PubMed ID: 11503831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].
    Rev Esp Salud Publica; 2000; 74(3):215-53. PubMed ID: 10918811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Classical risk factors for myocardial infarction and total mortality in the community--13-year follow-up of the MONICA Augsburg cohort study].
    Heidrich J; Wellmann J; Hense HW; Siebert E; Liese AD; Löwel H; Keil U
    Z Kardiol; 2003 Jun; 92(6):445-54. PubMed ID: 12819993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatable risk factors--hypercholesterolemia, smoking, and hypertension--after myocardial infarction: implications of the coronary drug project data for clinical management. Coronary Drug Project Research Group.
    Prim Care; 1980 Mar; 7(1):175-9. PubMed ID: 6992178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intervention in risk factors and protection of target organs].
    Gascón Ramón G; Bertomeu i Blanch F; Baño Aracil M; Madrigal JA
    An Med Interna; 1997 Sep; 14(9):478-84. PubMed ID: 9453760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Secondary prevention of arteriosclerosis].
    Hoffmann U; Leu AJ
    Praxis (Bern 1994); 1996 Sep; 85(39):1201-5. PubMed ID: 8927904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factors in acute myocardial infarct and cerebral ischemic disease].
    Negri M; Riva M; Broccolino M; Volpi M; Galbiati N
    Minerva Med; 1985 Sep; 76(34-35):1521-7. PubMed ID: 4034051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.